Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex ®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report

Dexamethasone intravitreal implants (0.7  mg) (Ozurdex®, Allergan Inc., Madison, NJ) are FDA approved for managing macular oedema (ME) of retinal vein occlusion (RVO). The major complications associated with in...

Source: BMC Ophthalmology - June 22, 2020 Category: Opthalmology Authors: Zhi-Yong Zhang, Xiu-Yun Liu and Tao Jiang Tags: Case report Source Type: research